Sickle Cell Drug Approved for Children Ages Four to 11.

Anemia, Sickle Cell / drug therapy Child Child, Preschool Humans

Journal

The American journal of nursing
ISSN: 1538-7488
Titre abrégé: Am J Nurs
Pays: United States
ID NLM: 0372646

Informations de publication

Date de publication:
01 04 2022
Historique:
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 14 4 2022
Statut: ppublish

Résumé

Voxelotor (Oxbryta) has received accelerated approval to treat sickle cell disease in children ages four to 11 years. This is a new indication for the drug.Voxelotor prevents red blood cells from forming a sickle shape, reducing the damage to tissues and red blood cells that is common with sickle cell disease.

Identifiants

DOI: 10.1097/01.NAJ.0000827312.29859.99 PMID: 35348512
pubmed: 35348512
doi: 10.1097/01.NAJ.0000827312.29859.99
pii: 00000446-202204000-00018
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-21

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Auteurs

Diane S Aschenbrenner (DS)

Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch:diane.aschenbrenner@gmail.com .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Hémoglobinopathies › Drépanocytose › Sickle Cell Drug Approved for Children Ages Four to 11.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Sickle Cell Drug Approved for Children Ages Four to 11.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Sickle Cell Drug Approved for Children Ages Four to 11.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Sickle Cell Drug Approved for Children Ages Four to 11.